Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Ipilimumab for Head and Neck Cancer Patients [Phase 1]
A Phase 1 clinical trial evaluating ipilimumab for squamous cell carcinoma of the head and neck is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Nutrition and Life QUality Patients With Head and Neck Cancers [NA]
This entry notes the completion of a clinical trial evaluating nutrition and quality of life in patients with head and neck squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer [Phase 1]
Phase 1 safety study evaluating afatinib in combination with postoperative radiation therapy for squamous cell carcinoma of the head and nec…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in combination with pembrolizumab for metastatic solid tumors has completed, enrolling patients with me…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer [Phase 2]
Randomized Phase II study evaluated DCE-MRI–guided dose escalation for poor-prognosis squamous cell carcinoma of the head and neck. The tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]
Phase 1 study of PF-07826390 in cancer patients, including non-small cell lung cancer, was terminated; the trial evaluated different doses o…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) [Phase 3]
Phase III XRAY VISION trial evaluating Xevinapant with radiotherapy in resected locally advanced head and neck squamous cell carcinoma in ci…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab for relapsed, locally recurrent squamous cell carcinoma of the head and neck; the study is…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with chemoradiotherapy for squamous cell carcinoma of the head and neck; the trial was…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Takeda's TAK-186 (MVC-101) was studied in a Phase 1/2 trial for adults with advanced or metastatic cancers including squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) [Phase 3]
Phase 3 trial evaluating Xevinapant in combination with platinum-based chemotherapy and radiotherapy for locally advanced squamous cell carc…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer) [Phase 1, Phase 2]
A Phase 1/2 study evaluating multiple treatment combinations in locally advanced squamous cell carcinoma of the head and neck has completed,…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors [Phase 1]
Phase 1a/1b study of TPST-1495 as monotherapy and in combination with pembrolizumab has completed status, spanning multiple solid tumors inc…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers [Phase 1]
Phase 1 trial evaluating TAK-676 in combination with pembrolizumab after radiation therapy across several cancers; the study completed and p…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Study of INCA 0186 in Subjects With Advanced Solid Tumors [Phase 1]
A Phase 1 study of INCA 0186 in patients with advanced solid tumors, including squamous cell carcinoma of the head and neck, has been termin…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN [Phase 2]
Phase 2 trial evaluating durvalumab with radiotherapy as adjuvant treatment for intermediate-risk squamous cell carcinoma of the head and ne…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma [Phase 1]
Phase 1 study evaluating radiotherapy with durvalumab before surgical resection for HPV-negative squamous cell carcinoma of the head and nec…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
This clinical trial update reports the completion of an observational study in Germany evaluating nivolumab in patients with squamous cell c…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC [NA]
A completed clinical trial comparing margin-based and robust photon radiotherapy planning for IMRT in head and neck squamous cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Priming Immunotherapy in Advanced Disease With Radiation [Phase 2]
This is a Phase 2 clinical trial update evaluating priming immunotherapy in combination with radiation for advanced disease. Results have be…